Lithium succinate

Clinical data
Other names	Lithium succinate dibasic
AHFS/Drugs.com	Monograph
ATC code	D11AX04 (WHO)
Identifiers
IUPAC name Dilithium butanedioate
CAS Number	29126-50-9
PubChemCID	10197702
DrugBank	DB14508 Y
ChemSpider	8373202 Y
UNII	MD64P82Y28
ChEMBL	ChEMBL3707288
ECHA InfoCard	100.163.153
Chemical and physical data
Formula	C4H4Li2O4
Molar mass	129.95 g·mol−1
3D model (JSmol)	Interactive image
SMILES [Li+].[Li+].[O-]C(=O)CCC([O-])=O
InChI InChI=1S/C4H6O4.2Li/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2 Y Key:WAHQBNXSPALNEA-UHFFFAOYSA-L Y
(verify)

Lithium succinate (C₄H₄Li₂O₄), thedilithiumsalt ofsuccinic acid, is a drug used in the treatment ofseborrhoeic dermatitis^[1] and proposed for the treatment ofanogenital warts.^[2]

• "Lithium succinate".Drug Information Portal. U.S. National Library of Medicine. Archived fromthe original on November 4, 2022.

Thisdermatologicdrug article is astub. You can help Wikipedia byadding missing information.

• v
• t
• e

• Lithium salts
• Succinates
• Dermatologic drug stubs

• Articles with short description
• Short description matches Wikidata
• Short description is different from Wikidata
• ECHA InfoCard ID from Wikidata
• Articles without KEGG source
• Drugs with no legal status
• All stub articles